director

Visma is a collective of over 180 SaaS companies, dedicated to providing innovative cloud software solutions that simplify complex business processes for a variety of customers, including small businesses, accounting firms, and public sector organizations. Their software offerings encompass areas such as accounting, ERP, HRM, payroll, and workforce management, supporting millions in their daily operations.

Visma is a leading provider of mission-critical business software for a more efficient and resilient society. By simplifying and automating the work of companies and organisations of all sizes, we improve people's everyday lives. With 15,000 employees, 1,700,000 private and public sector customers across Europe and Latin America, and net revenue of €2,056 million in 2022, we are committed to making tomorrow better than today. Visit us at visma.com.

Visma

• Do you want to drive innovation, product development, and AI excellence across Visma companies?
• In this role, you will drive product development and AI excellence, supporting management teams in improving and innovating.
• You will report to Visma’s CTO, Tinius Alexander Lystad, and collaborate with fellow PD Directors, Managing Directors, and CTOs to help shape and execute product strategies for the age of AI.
• Proactively identifying and executing the most impactful AI and product improvements across selected companies.
• Respecting each company’s uniqueness, helping individual units focus on what moves the needle for them and for the Visma Group as a whole.
• Contributing to M&A due diligence processes and the onboarding of newly acquired companies.
• Participating in boards within the relevant Business Area and guiding R&D investments.

Product Development Director

Product Development Director driving innovation and AI excellence across Visma companies. Collaborating with management teams to enhance product strategies for the age of AI.

Novo Nordisk is a global healthcare company that has been at the forefront of research in obesity and diabetes for over 25 years. Their mission is to improve the lives of people suffering from obesity and diabetes through innovative treatments and sustainable practices. With a strong commitment to patient safety, Novo Nordisk actively combats falsified medicines and strives to enhance the integrity of their products. They offer a range of life-saving medications and are dedicated to driving change in the healthcare landscape, ensuring that children and adults alike have access to essential medical care.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.

This page isn’t intended for discussions about products.  As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. 

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: 
https://www.novonordisk.com/contact-us/find-local-information.html

For other customer complaints, please contact us here: 
https://www.novonordisk.com/contact-us.html

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed. 

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

Learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines

Novo Nordisk

• Establish and lead a new, high‑impact team focused on next‑generation clinical data review and analytics across rare disease and CKAD portfolios.
• Drive strategic initiatives, build technical and reporting capabilities, and ensure delivery of robust, data‑driven insights that strengthen clinical quality, risk management and decision‑making across Development.
• Build and lead the Centralized Data Review team for Rare Disease and CKAD, setting targets, developing competencies and ensuring timely, high‑quality delivery.
• Lead large cross‑functional transformation programs (e.g., IQRMA), owning project delivery and translating complex clinical data topics into clear priorities for stakeholders.
• Establish a Centre of Excellence for data review reports, dashboards and visualisations, evaluating and implementing emerging technologies (including AI/ML) to enhance analytics.
• Ensure optimal resource allocation and operational performance by coordinating staffing, budgets and vendor engagement, and by monitoring deliverables and costs.
• Champion continuous improvement and quality by defining standards, sharing best practices, supporting audits, and promoting trustworthiness and compliance in clinical data handling.

Director, CDR, CKAD, RD & Transformation

Director leading Centralized Data Review and digital transformation in rare disease at Novo Nordisk. Managing a team and driving data-driven insights across clinical development.

Nexi Group is a leading European payment technology company, often referred to as 'The European PayTech'. It is engaged in providing a range of digital payment solutions and services to businesses of all sizes, consumers, banks and financial institutions, and public sector entities. The company offers payment acceptance, mobile payments, digital corporate banking, open banking, trade surveillance, compliance solutions, and blockchain technologies. They operate across various sectors including medium and large enterprises, small businesses, central institutions, and public sector clients. With a robust presence in over 25 countries, Nexi Group serves approximately 2.9 million merchants and handles around 140 million cards. Their solutions are aimed at driving payment innovation and enhancing the overall payment experience.

We come from the merger and integration of Nexi, Nets and Sia, among the biggest European players in digital payments. 
European by scale, local by nature we are now present in more than 25 countries.

We have the scale, capabilities and proximity to provide the simplest, fastest and safest payment solutions to People, Businesses and Financial Institutions.

We help our Customers pay and accept digital payments through a complete and personalised range of simple, intuitive and secure solutions.

We offer Banks, Small and Medium-sized Enterprises, Large International Corporations, Institutions and Public Administrations a complete range of innovative solutions for digital payments in both card‑present and card‑not‑present acceptance, e-commerce and multi-channel solutions. 

We want to shape the way People pay and Businesses accept payments, by offering to our customers the most innovative and reliable solutions, thanks to our scale and the competence and energy of our people. 

We will drive the transition to a cashless Europe by making every payment digital because it is simpler, faster and safer for everyone.

We strongly contribute to Europe’s digitalisation, managing our business in a sustainable way and with great attention to the environment, as well as to a transparent governance and to society. 

We drive progress by simplifying transactions and by empowering people and businesses to enjoy closer relationships and prosper together.

Nexi Group

• Drive product adoption, penetration, and merchant satisfaction across Nordic markets in partnership with regional sales leadership.
• Capture Nordic payment market dynamics, competitive movements, and merchant needs. Translate these into prioritized requirements that influence global roadmaps.
• Ensure global products meet local market regulations and work effectively in Nordic markets. Coordinate regional adaptations for payment methods, merchant portals, and market-specific needs.
• Provide product training, RFP support, and technical consultation to help close deals.
• Own demand planning across all product towers, ensuring development capacity aligns with priorities and ROI opportunities.

Product Director

Product Director responsible for driving merchant product success across Nordic markets at an exciting paytech company. Collaborating with leadership for product strategy and regional market fit.

Ipsos is one of the world’s leading independent market research companies controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a global research group with a presence in 89 countries.

Ipsos researchers assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media and they measure public opinion around the globe. 

Simply put, Ipsos knows people. As one of the most innovative market research companies in the world we are constantly evolving to deliver a total understanding of people, society and the markets we all trade in.


Ipsos North America

• Engage with and manage clients within Innovation
• Design and write top class proposals
• Deliver top class insights and actionable recommendations to help clients be successful in their strategy and marketing decisions
• Present for, and conduct workshops with, stakeholders at all levels
• Responsible for client relationship and client satisfaction for assigned clients and new business
• Collaborate effectively with colleagues within Ipsos to assure quality and client management
• Support training activities and knowledge sharing
• Manage projects effectively and understand what drives project profitability

Director – Innovation Team

Director overseeing client management and project proposals in the Innovation domain at Ipsos Denmark. Collaborating with a team to deliver insights and recommendations to clients.

Genmab is a biotechnology company focused on transforming lives through pioneering antibody science. The company is dedicated to developing innovative antibody therapeutics for various diseases, aiming to improve patient outcomes and treatment options. Genmab's efforts in antibody research and development highlight its commitment to advancing medical science.

We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM  experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com.  
Disclaimer: http://bit.ly/GENDisclaimer

Genmab

• Execute plans with great technical depth and breadth (training & compliance, project management, medical education, grants & sponsorships)
• Define work instructions/process flows within own area/study
• Implement delivery plans and provide periodic reporting in line with overall CoE strategy (e.g. project metrics, training outcomes, grant outcomes, budgets, vendor metrics)
• Guide cross-functional and direct team members to drive compliance and address issues related to deliverables
• Actively contribute in teams and meetings, collaborate with other medical affairs groups and external stakeholders as required
• Train and mentor others around new technologies and scientific aspects of applied scientific research
• Oversee successful implementation of Investigator-Driven programs
• Successfully develop, implement, and manage Investigator-Driven Programs
• Execute formal review process for proposals, protocols, and amendments
• Facilitate review committee meetings and document decisions
• Drive operational timelines and key deliverables for the program or project
• Manage proposal lifecycle from submission to study closure
• Provide guidance and oversight for the successful management of all aspects of investigator-driven programs within designated program budgets and timelines
• Partner with cross-functional teams and alliance partners to manage, adjust, and revise project timelines/budgets as necessary
• Generate regular metrics and reports of program activities and present them to leadership and strategy team as needed
• Support field-based teams and MASL teams in executing project/program goals
• Work cross-functionally with internal teams which may include development, research, legal, finance, supply chain, and regulatory
• Independently manage ISTs including site coordination, document management, and drug shipment and payments
• Contribute to contract review and negotiations
• Communicate project status and issues and ensure project team goals are met
• Represent the department at cross-departmental events, as needed
• Functional expertise to initiate, author, or contribute to SOP development, implementation, and training
• Anticipate moderately complex obstacles and client difficulties and implements solutions to achieve project goals
• Participate in process improvement exercises to drive operational excellence.

Associate Director, Evidence Generation

Associate Director overseeing evidence generation projects for cancer treatments at Genmab. Focus on managing programs, compliance, and collaborating across teams in a hybrid work environment.

HBK - Hottinger Brüel & Kjær is a prominent company formed in 2019 through the merger of HBM and Brüel & Kjær, two organizations with over 80 years of experience in precision test and measurement technology. HBK delivers innovative solutions across multiple domains including mechanical, sound and vibration, and electrical testing. The company provides a wide range of products and services such as data acquisition systems, electroacoustic setups, vibration testing equipment, and custom sensor assemblies. HBK caters to diverse industries such as aerospace, automotive, and energy, focusing on quality, reliability, and sustainability in all offerings. The company's mission is to empower innovators by providing exceptional sensing and insights, thus contributing to a cleaner, healthier, and more productive world.

Hottinger Brüel & Kjær was founded in 2019, when HBM and Brüel & Kjær merged their activities into a new company. 

Both companies are market leaders in their respective disciplines – Brüel & Kjær in sound and vibration and HBM in reliability, durability, propulsion efficiency and weighing. Together, they cover the complete product physics domain. In technical terms, Brüel & Kjær is the frequency domain expert and HBM the time domain expert. 

HBK helps its customers reduce time-to-market by simultaneously performing tests, retrieving and analyzing data, aiding decision-making.

HBK - Hottinger Brüel & Kjær

• Create and execute a comprehensive digital product strategy
• Conduct a thorough analysis of the current software strategy
• Develop a detailed roadmap for the digital product strategy
• Establish and monitor key performance indicators for the digital product strategy
• Engage and communicate with internal and external stakeholders
• Influence and inspire teams across different functions and regions
• Explore and evaluate new technologies that enhance product offerings

Director – Digital Revenue

Digital Revenue Director creating comprehensive strategies leveraging digital technologies for HBK. Collaborating with global teams to enhance customer value and drive innovation in measurement solutions.

Hybrid Directors roles in Denmark

Browse 6 hybrid directors roles hiring in Denmark plus related opportunities such as vice president, chief marketing officer and engineering manager.

6 jobs found